FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称RAMUCIRUMAB
异名/同义词1121B
CYRAMZA
IMC-1121B
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR TYPE VEGFR-2 EXTRACELLULAR DOMAIN) (HUMAN MONOCLONAL IMC-1121B .GAMMA.-CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL IMC-1121B .KAPPA.-CHAIN, DIMER
LY3009806
RAMUCIRUMAB
RAMUCIRUMAB [INN]
RAMUCIRUMAB [JAN]
RAMUCIRUMAB [MART.]
RAMUCIRUMAB [MI]
RAMUCIRUMAB [PURPLE BOOK CDER]
RAMUCIRUMAB [USAN]
RAMUCIRUMAB [VANDF]
RAMUCIRUMAB [WHO-DD]
CAS登记号947687-13-0
物质唯一标识(Unique Ingredient Identifier)D99YVK4L0X
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System